|
2024
|
Volume
|
|
Glucose-6-Phosphate Dehydrogenase
|
3 |
|
Body Fluid Lower Reportable Cell Count Ranges
|
2 |
|
Requirement changes for 24-hour Urine Preservative
|
1 |
|
2023
|
Volume
|
|
Munson Medical Center Immature Granulocyte (IG) Reporting
|
14 |
|
Collection and Instrument Updated Roche CTGC and TVDNA
|
13 |
|
Changes to Clostridioides Difficile Testing
|
12 |
|
Tick Borne Pathogens Anaplasma
|
11 |
|
Munson Medical Center Lab Hematology Testing Transitioning to New Platform
|
10 |
|
MHC Standardizing Lab Critical Values
|
9 |
|
Rhlg from Ortho Rhogam to CSL Behring Rhophylac
|
8 |
|
Collection Changes for and Instrument changes for Chlamydia trachomatis Neisseria gonorrhoeae and Trichomonas vaginalis
|
7 |
|
Chemistry Automation Line – Specimen Stability
|
6 |
|
eGFR Calculations
|
5 |
|
Infectious Vaginitis Testing
|
4 |
|
Changes to Urine Drug of Abuse Screen Testing
|
3 |
|
Heparin-Induced Thrombocytonpenia (HIT) Testing
|
2 |
|
D-dimer Reporting
|
1 |
|
2022
|
Volume
|
|
Discontinuation of Direct Bilirubin and Total Bilirubin Reflex Test
|
6 |
|
Michigan Lyme Disease Testing
|
5 |
|
GI (Diarrhea) Testing Panel Update
|
4 |
|
Stago Coagulation Analyzers -- Cadillac Hospital
|
3 |
|
Biofire Bacterial Pathogen Resistance Gene Testing
|
2 |
|
Group A Strep Test Communication
|
1 |
|
2021
|
Volume
|
|
Electronic Crossmatch and ABO Verification and History Check
|
16 |
|
Respiratory Syncytial Virus (RSV)
|
15 |
|
Stago Coagulation Analyzers
|
14 |
|
Respiratory testing for 2021-2022
|
13 |
|
Specimen Rejection Policy – Clinical Laboratory Specimens
|
12 |
|
Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification | GI Reimbursement Memo
|
11 |
|
Submitting specimens for laboratory testing
|
10 |
|
Increased range of results for reporting urinalysis chemistry analytes
|
9 |
|
Serum and Urine: Immunoglobulin, Complement, Immunofixation, Free Light Chain and Electrophoresis, testing to Mayo
|
8 |
|
ABO Verification and History Check
|
7 |
|
Urine specimens for Chlamydia, Gonorrhea, & Trichomonas
|
6 |
|
COVIDP GIP CTGC and CRYO Updates
|
5 |
|
Gastrointestinal Pathogen PCR Panel
|
4 |
|
The Paris System for Reporting Urine Cytology
|
3 |
|
Influenza and RSV Testing
|
2 |
|
Group A Strep Test Communication
|
1 |
|
2020
|
Volume
|
|
EV replacement Urine for CTGC Group A strep testing
|
8 |
|
Gonorrhea and Chlamydia Samples
|
7 |
|
Immunology Testing
|
6 |
|
Chlamydia, Neisseria, Trichomonas Testing
|
5 |
|
Reporting of Magnesium Results
|
4 |
|
Pertussis and Lyme Disease
|
3 |
|
Reporting of Magnesium Results
|
2 |
|
Microbiology Changes
|
1
|
|
2019
|
Volume
|
|
Policy regarding Skin Specimen for Frozen Sections
|
5
|
|
Helicobacter Pylori Stool Antigen Testing
|
4
|
|
VerifyNow Testing Platform
|
3
|
|
Measles
|
2
|
|
Removal of the test "Reducing Substances, Urine" | Removal of the test "Magnesium, Red Blood Cell"
|
1 |
|
2018
|
Volume |
|
Fluoroquinolones
|
4
|
|
Kappa and Lambda Immunoglobulin Free Light Chain Testing
|
3 |
|
Clostridium Difficile Testing
|
2 |
|
p02 and pC02 Discontinued Tests
|
1 |
|
2017
|
Volume
|
|
Immunoassays at MMC II
|
11
|
|
Troponins New Reference Range
|
10
|
|
Clostridium Difficile Testing
|
9
|
|
Immunoassays at MMC
|
8
|
|
Hepatitis C Screening Test Now Available
|
7
|
|
Helicobacter Pylori Testing
|
6
|
|
Plasma
|
5
|
|
Absolute Neutrophil Count (ANC)
|
4
|
|
Urine Culture
|
3
|
|
Post-Vasectomy Semen Analysis (PVSA)
|
2
|
|
Upgraded Assay for Thyroid Function Cascade and TSH Testing
|
1
|